Companies: 10,795·Total market cap: $144.5T
EOM Pharmaceuticals Holdings, Inc.

EOM Pharmaceuticals Holdings, Inc.

IMUCOTCHealthcare● Active
$0.27
+$0.06(+27.02%)
Market Cap$30571843
P/E Ratio
52W High$0.34
52W Low$0.036
Overview

EOM Pharmaceuticals Holdings, Inc. (IMUC) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · IMUC · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.02imuc eps ttm · imuc earnings per shareEarnings history
PE Ratio (TTM)imuc pe ratio ttm · imuc price to earningsPE Ratio deep dive
Revenue (TTM)0.00imuc revenue ttm · imuc annual revenueFull revenue history
Dividend YieldNo Dividenddoes imuc pay dividends · imuc dividend yieldDividend history
Shares Outstanding126.5Mimuc shares outstanding · imuc floatShares outstanding history
Next EarningsTBAimuc earnings date · imuc next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
eom pharmaceuticals holdings, inc. revenue · imuc revenue 2025
FY 2025Net Income-$1.9M▼ 1.61% YoY
202320242025
eom pharmaceuticals holdings, inc. net income · imuc profit 2025
FY 2025EPS$-0.02▲ +7.32% YoY
202320242025
imuc eps · eom pharmaceuticals holdings, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$2.6MEPS: $-0.02View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold3 analystsis imuc a buy · imuc analyst rating
Strong Buy
0
Buy
0
Hold
3
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.27Current
$Avg Target
$High
imuc price target · imuc 12 month forecast

Total: 3 · Buy rate: 0.0%

Stock Performance

Full History
1D+25.00%
1W+47.06%
1M+85.19%
3M+49.49%
YTD+252.11%
1Y+134.08%
5Y-61.54%

About EOM Pharmaceuticals Holdings, Inc.

CEOIrach Taraporewala
IPO DateJan 8, 2021
Employees3
CountryUS

EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medications. These treatments hold the potential to revolutionize existing therapeutic …

what is eom pharmaceuticals holdings, inc. · imuc stock overview · eom pharmaceuticals holdings, inc. company profile · who is eom pharmaceuticals holdings, inc. ceo · imuc OTC · eom pharmaceuticals holdings, inc. headquarters · eom pharmaceuticals holdings, inc. business segments

About Stock Overview & Key Data

EOM Pharmaceuticals Holdings, Inc. (IMUC) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 8, 2021. As of the latest trading session, IMUC stock price is $0.27, with a market capitalization of $30.6M. The stock has returned +134.08% over the past 12 months and +252.11% year-to-date.

According to 3 Wall Street analysts, the consensus rating for EOM Pharmaceuticals Holdings, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, EOM Pharmaceuticals Holdings, Inc. reported revenue of — and net income of -$1.9M. For detailed data — including EOM Pharmaceuticals Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, EOM Pharmaceuticals Holdings, Inc. (IMUC) stock price is $0.27. The stock is traded on OTC under the ticker symbol IMUC. The 52-week range is $0.04 – $0.34.

IMUC stock priceIMUC quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice